@article{article, title  = {{IMvigor 210, a phase II trial of atezolizumab (MPDL3280A) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC).}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{}},

 year = {{2016}},

 month = {{1}},

 author = {{Hoffman-Censits JH and Grivas P and Van Der Heijden MS and Dreicer R and Loriot Y and Retz M and Vogelzang NJ and Perez-Gracia JL and Rezazadeh A and Bracarda S and Yu EY et al}},

 doi = {{10.1200/jco.2016.34.2_suppl.355}},

 volume = {{34}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{2_suppl}},

 pages = {{355-355}},

 note = {{Accessed on 2024/12/22}}}